Trials / Unknown
UnknownNCT00809575
Quality of Life and Symptoms in Patients With Newly Diagnosed Myelodysplastic Syndromes
Prognostic Significance and Longitudinal Assessment of Patient-reported Quality of Life and Symptoms in Myelodysplastic Syndromes. A Large-scale International, Observational Study: PROMYS Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 927 (actual)
- Sponsor
- Gruppo Italiano Malattie EMatologiche dell'Adulto · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Gathering information about quality of life, fatigue, and other symptoms from patients with myelodysplastic syndromes may help doctors learn more about the disease and may help plan treatment. PURPOSE: This clinical trial is studying quality of life and symptoms in patients with newly diagnosed myelodysplastic syndromes.
Detailed description
This study will ultimately aim at providing the scientific community with additional patient-reported health status data to support and further facilitate the clinical decision-making process. This project has thus a number of goals. The main objective of the protocol is to improve our understanding of the possible added prognostic value of patients' judgment on their own health status and its potential clinical implications. This would aim at providing clinicians with an easy and brief to administer patient-reported health status scale or tool to be used to make more informed treatment decisions. In addition, along with other recent evidence (also looking at the prognostic value of patients' health status judgment in MDS patients), the data of this research could possibly serve to devise a patient-based prognostic index to be used in this higher risk population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | questionnaire administration | |
| OTHER | fatigue assessment and management | |
| OTHER | observation | |
| OTHER | quality-of-life assessment |
Timeline
- Start date
- 2008-10-02
- Primary completion
- 2018-10-08
- Completion
- 2021-02-01
- First posted
- 2008-12-17
- Last updated
- 2020-12-22
Locations
53 sites across 12 countries: United States, Austria, Belgium, Brazil, China, Croatia, Czechia, France, Germany, Italy, Taiwan, United Kingdom
Source: ClinicalTrials.gov record NCT00809575. Inclusion in this directory is not an endorsement.